Rebecca Black has currently started a new role as Deputy Director of Clinical Operations in which she will work closely with the Director of Clinical Operations to oversee National Capital’s residential programs. Previous to this role, she was the program director for Demeter House. In that position, she was responsible for clinical operations of Demeter House, NCTR’s residential program for women, to assure that high quality treatment services are provided to all patients. Prior to joining National Capital Treatment & Recovery, she worked for seven years as an inpatient clinical manager at Pathways-Luminis Health in Maryland. She is a licensed clinical social worker with 13 years of experience in the substance use disorder treatment field. She has a Master of Social Work degree from the University of Maryland, Baltimore. She is also an Adjunct Professor at Anne Arundel County Community College, in Maryland.

Gladys Brown is the Nurse Practitioner Manager at Demeter House, NCTR’s residential treatment program for women. She is responsible for ensuring that all patients receive optimal medical care during their journey to recovery. She is a board-certified adult-gerontology nurse practitioner (AGNP-BC) with 12 years of experience in behavioral health and substance use disorder services. Gladys holds a Master of Science in nursing degree from Spring Arbor University in Michigan.

Dr. Mary Lee received her medical degree from Columbia University College of Physicians and Surgeons in 1989. She completed residency in internal medicine at Columbia Presbyterian Medical Center and subsequently completed a psychiatric residency at George Washington University. Dr. Lee is board certified in psychiatry, internal medicine, and addiction medicine. She joined the CPN laboratory in November of 2012. Her research has focused on the effect of intranasal oxytocin on drug craving, reward learning, and emotional processing in drug dependent and schizophrenic patients. In addition, she has investigated the neurobehavioral effects of genetic polymorphisms, COMT and OPRM, on reward processing in smokers and drug users. Her current research is on the role of oxytocin in alcohol and drug use disorders. She was the PI of a translational and clinical project studying the role of oxytocin in alcohol use disorder for which she received a NIH Bench-to-Bedside (B2B) Award by the Office of Behavioral & Social Sciences Research (OBSSR). She is collaborating with George Mason University on a project funded by the Department of Defense aimed at investigating the role of oxytocin in long-term bonding. In 2018, Dr. Lee was presented with the NIAAA Clinical Service Award.